These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8751535)

  • 21. [A device for the continuous-flow extracorporeal irradiation of the blood].
    Kompaniets NG
    Klin Khir; 1996; (7):45-6. PubMed ID: 9044787
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitigation of coagulation by removing clotting factors part 2: heparin-free extracorporeal circulation in a porcine model.
    Sukavaneshvar S; Parker JT; Beutler DS; Burns G; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):421-7. PubMed ID: 17667225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirements.
    Despotis GJ; Levine V; Alsoufiev A; Joist H; Goodnough LT; Pasque M
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):538-40. PubMed ID: 8751525
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
    Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bound and circulating heparin in an ECMO system thrombogenicity versus functionality.
    Roohk HV; Calabrese D; Sanematsu L; Castillo G; Cottonaro CN
    Trans Am Soc Artif Intern Organs; 1984; 30():639-43. PubMed ID: 6533950
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 27. [The principles of minimal extracorporeal circulation and its uses].
    Göbölös L; Hejjel L; Lindenmayer-G R; Wiebe K; Philipp A; Foltan M; Ziegler S; Imre J; Sipos E; Gyorimolnár I; Papp L
    Orv Hetil; 2007 Nov; 148(46):2167-71. PubMed ID: 17988973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative autotransfusion.
    Glover JL; Broadie TA
    Prog Clin Biol Res; 1982; 108():151-70. PubMed ID: 6757958
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonthrombogenic surfaces: critical review.
    Salzman EW
    Blood; 1971 Oct; 38(4):509-23. PubMed ID: 4937027
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery bypass graft with minimal extracorporeal circulation.
    Folliguet TA; Villa E; Vandeneyden F; Laborde F
    Heart Surg Forum; 2003; 6(5):297-301. PubMed ID: 14721797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic and hemorrhagic problems in surgery.
    Rodvien R; Salzman EW
    Thromb Haemost; 1978 Apr; 39(2):254-62. PubMed ID: 580981
    [No Abstract]   [Full Text] [Related]  

  • 34. Biologically active heparin coating in medical devices.
    Olsson P; Larm O
    Int J Artif Organs; 1991 Aug; 14(8):453-6. PubMed ID: 1937934
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The "benefits" of the mini-extracorporeal circulation in the minimal invasive cardiac surgery era.
    Baikoussis NG; Papakonstantinou NA; Apostolakis E
    J Cardiol; 2014 Jun; 63(6):391-6. PubMed ID: 24629908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticoagulation for pediatric mechanical circulatory support.
    Annich G; Adachi I
    Pediatr Crit Care Med; 2013 Jun; 14(5 Suppl 1):S37-42. PubMed ID: 23735984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial-venous perfusion without anticoagulation: the impeller centrifugal pump.
    Vertrees RA; Yu Y; Wacker C; Cernaianu AC; DelRossi AJ
    J Extra Corpor Technol; 1991; 22(4):160-3. PubMed ID: 10149016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiopulmonary bypass over 24 hours without systemic anticoagulation: new horizons?].
    von Segesser LK; Turina M
    Helv Chir Acta; 1990 Oct; 57(2):389-93. PubMed ID: 2074206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.